Skip to main content
Journal cover image

Strategies for Mechanical Right Ventricular Support During Left Ventricular Assist Device Implant.

Publication ,  Journal Article
Beller, JP; Mehaffey, JH; Wegermann, ZK; Grau-Sepulveda, M; O'Brien, SM; Brennan, JM; Thourani, V; Badhwar, V; Pagani, FD; Ailawadi, G ...
Published in: Ann Thorac Surg
August 2022

BACKGROUND: Refractory right ventricular failure at the time of left ventricular assist device implantation requires treatment with supplemental mechanical circulatory support. However, the optimal strategy for support remains unknown. METHODS: All patients undergoing first-time durable left ventricular assist device implantation with a contemporary device were selected from The Society of Thoracic Surgeons National Database (2011 to 2019). Patients requiring right ventricular assist device (RVAD) or venoarterial extracorporeal membrane oxygenation (VA-ECMO) were included in the analysis. Patients were stratified by RVAD or VA-ECMO and by timing of placement (intraoperative vs postoperative). RESULTS: In all, 18 423 left ventricular assist device implants were identified, of which 940 (5.1%) required RVAD (n = 750) or VA-ECMO (n = 190) support. Patients receiving an RVAD more frequently had preoperative inotrope requirement (76% vs 62%, P < .01) and severe tricuspid regurgitation (20% vs 13%, P < .01). The RVAD patients had lower rates of postoperative renal failure (40% vs 51%, P = .02) and limb ischemia (4% vs 13%, P < .01), as well as significantly less operative mortality (41% vs 54%, P < .01). After risk adjustment with propensity score analysis, support with VA-ECMO was associated with a higher risk of mortality (risk ratio 1.46; 95% confidence interval, 1.21 to 1.77; P < .01) compared with patients receiving an RVAD. Importantly, institution of right ventricular support postoperatively was associated with higher mortality (1.43, P < .01) compared with intraoperative initiation. CONCLUSIONS: Patients with severe right ventricular failure in the setting of durable left ventricular assist device implantation may benefit from the use of RVAD over VA-ECMO. Regardless of the type of support, initiation at the index operation was associated with improved outcomes.

Duke Scholars

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

August 2022

Volume

114

Issue

2

Start / End Page

484 / 491

Location

Netherlands

Related Subject Headings

  • Ventricular Dysfunction, Right
  • Treatment Outcome
  • Retrospective Studies
  • Respiratory System
  • Humans
  • Heart-Assist Devices
  • Heart Failure
  • Extracorporeal Membrane Oxygenation
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Beller, J. P., Mehaffey, J. H., Wegermann, Z. K., Grau-Sepulveda, M., O’Brien, S. M., Brennan, J. M., … Teman, N. R. (2022). Strategies for Mechanical Right Ventricular Support During Left Ventricular Assist Device Implant. Ann Thorac Surg, 114(2), 484–491. https://doi.org/10.1016/j.athoracsur.2021.10.032
Beller, Jared P., J Hunter Mehaffey, Zachary K. Wegermann, Maria Grau-Sepulveda, Sean M. O’Brien, J Matthew Brennan, Vinod Thourani, et al. “Strategies for Mechanical Right Ventricular Support During Left Ventricular Assist Device Implant.Ann Thorac Surg 114, no. 2 (August 2022): 484–91. https://doi.org/10.1016/j.athoracsur.2021.10.032.
Beller JP, Mehaffey JH, Wegermann ZK, Grau-Sepulveda M, O’Brien SM, Brennan JM, et al. Strategies for Mechanical Right Ventricular Support During Left Ventricular Assist Device Implant. Ann Thorac Surg. 2022 Aug;114(2):484–91.
Beller, Jared P., et al. “Strategies for Mechanical Right Ventricular Support During Left Ventricular Assist Device Implant.Ann Thorac Surg, vol. 114, no. 2, Aug. 2022, pp. 484–91. Pubmed, doi:10.1016/j.athoracsur.2021.10.032.
Beller JP, Mehaffey JH, Wegermann ZK, Grau-Sepulveda M, O’Brien SM, Brennan JM, Thourani V, Badhwar V, Pagani FD, Ailawadi G, Yarboro LT, Teman NR. Strategies for Mechanical Right Ventricular Support During Left Ventricular Assist Device Implant. Ann Thorac Surg. 2022 Aug;114(2):484–491.
Journal cover image

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

August 2022

Volume

114

Issue

2

Start / End Page

484 / 491

Location

Netherlands

Related Subject Headings

  • Ventricular Dysfunction, Right
  • Treatment Outcome
  • Retrospective Studies
  • Respiratory System
  • Humans
  • Heart-Assist Devices
  • Heart Failure
  • Extracorporeal Membrane Oxygenation
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology